Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00918762 · ClinicalTrials.gov registry record · Phase 1
Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx
A Phase 1 study, sponsored by Barbara Ann Karmanos Cancer Institute.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00918762 is a Phase 1 study that has completed, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 6 participants.
The verdict
NCT00918762, a Phase 1 study, has completed, sponsored by Barbara Ann Karmanos Cancer Institute.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
RATIONALE: Transoral robotic surgery may make it easier to find and remove benign or malignant tumors of the larynx and pharynx and cause less damage to normal tissue. It is not yet known whether transoral robotic surgery is more effective than standard surgery in diagnosing and treating larynx and pharynx tumors. PURPOSE: This phase I trial is studying how well transoral robotic surgery works compared with standard surgery in treating patients with benign or malignant tumors of the larynx or pharynx.
Interventions
- PROCEDURE therapeutic conventional surgery
- PROCEDURE quality-of-life assessment
- PROCEDURE assessment of therapy complications
- PROCEDURE diagnostic endoscopic surgery
- PROCEDURE therapeutic endoscopic surgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00918762
The ClinicalTrials.gov registry entry for NCT00918762 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which therapeutic conventional surgery is the first listed.
NCT00918762 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00918762 about?
NCT00918762 is a clinical study titled "Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx". RATIONALE: Transoral robotic surgery may make it easier to find and remove benign or malignant tumors of the larynx and pharynx and cause less damage to normal tissue. It is not yet known whether transoral robotic surgery is more effective than standard surgery in diagnosing and treating larynx and ...
What is the current status of trial NCT00918762?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2009-05. Estimated completion is 2010-10.
What interventions are being tested in trial NCT00918762?
The interventions under investigation include: therapeutic conventional surgery (PROCEDURE), quality-of-life assessment (PROCEDURE), assessment of therapy complications (PROCEDURE), diagnostic endoscopic surgery (PROCEDURE), therapeutic endoscopic surgery (PROCEDURE).
Who is sponsoring clinical trial NCT00918762?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.